MARKET

NAMSW

NAMSW

NewAmsterdam Pha
NASDAQ
19.38
0.00
0.00%
Opening 09:30 07/27 EDT
OPEN
--
PREV CLOSE
19.38
HIGH
--
LOW
--
VOLUME
0
TURNOVER
--
52 WEEK HIGH
30.45
52 WEEK LOW
10.23
MARKET CAP
--
P/E (TTM)
-10.9245
1D
5D
1M
3M
1Y
5Y
1D
Truist Financial Reaffirms Their Buy Rating on NewAmsterdam Pharma Company (NAMS)
TipRanks · 2h ago
Weekly Report: what happened at NAMS last week (0720-0724)?
Weekly Report · 4h ago
NewAmsterdam, Menarini Secure Positive CHMP Opinion For Obicetrapib & Evlarco To Treat Cholesterol
NASDAQ · 7h ago
NewAmsterdam Pharma: Obicetrapib Is More Than Another LDL-Lowering Pill
Seeking Alpha · 1d ago
Analysts’ Top Healthcare Picks: NewAmsterdam Pharma Company (NAMS), Zevra Therapeutics (ZVRA)
TipRanks · 2d ago
NewAmsterdam Pharma: Advancing EU Launch and CV Outcomes Pathway Underpins Unchanged $48 Price Target and Buy Rating
TipRanks · 2d ago
NewAmsterdam announces positive CHMP opinion for Ubeslo and Evlarco
TipRanks · 3d ago
Analysts Are Bullish on Top Healthcare Stocks: Merck & Company (MRK), Johnson & Johnson (JNJ)
TipRanks · 3d ago
More
About NAMSW
NewAmsterdam Pharma Company NV is a Netherlands based company. NewAmsterdam Pharma operates as a clinical-stage company and focuses on the research and development of transformative oral therapies for major cardiometabolic diseases. The Company is investigating obicetrapib, an oral, low-dose and once-daily, cholesteryl ester transfer protein (CETP) inhibitor, as the low-density lipoprotein cholesterol (LDL-C) lowering therapy to be used as an adjunct statin therapy for high-risk cardiovascular disease (CVD) patients. The Company is also testing obicetrapib as a fixed-dose combination therapy with ezetimibe in a secondary Phase 2 trial, ROSE2, for other diseases such as Alzheimer’s disease. The Company strives to offer its products around the world.

Webull offers NewAmsterdam Pharma Company NV stock information, including NASDAQ: NAMSW real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NAMSW stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NAMSW stock methods without spending real money on the virtual paper trading platform.